Synapsia Informatics Workbench is software designed to enable networked, knowledge-led discovery
Agilent Technologies Europe has introduced the first of the Agilent Synapsia Informatics Workbench family of software products that have been designed for the specific needs of scientists working in drug discovery.
The new software, which is available for order and shipping today, is expected to help pharmaceutical companies bring drugs to market more quickly. "By breaking the barrier between biology and chemistry, Synapsia enables multi-disciplinary scientists to work together to share their interpretations of data," said Chris van Ingen, senior vice president of Agilent's Life Sciences and Chemical Analysis business.
"This improves decision quality at each step of the discovery process, leading to more promising breakthroughs at the end of the drug pipeline." The volume and variety of data generated by discovery research has made it difficult to access, manage, interpret, share and apply findings efficiently in the drug discovery process.
To address that issue, Agilent created the Synapsia Informatics Workbench, a software designed to enable networked, knowledge-led discovery.
Synapsia helps researchers to synthesize their collective understanding by incorporating research from internal and external sources of both experimental and analytical information.
The ability to integrate knowledge and the underlying data enables scientists to make better and more informed decisions faster by providing access to the right information at the right time.
The software also supports hypothesis-driven research across distributed organizations where team members from different disciplines contribute to the discovery process.
The software provides a single environment for documentation of information related to a research project, enabling scientists to connect disparate information sources and make decisions that are based on the comprehensive understanding of a scientific process.
Due to the software's open architecture, documented application programming interfaces, and use of standard formats capabilities for specific application environments can easily be extended within the software.
For users who would like to build compound related project models and to further analyze chemical compound data, Synapsia allows visual analysis/filtering of compound data and creation of compound-centric models through the workbench interface.
Key capabilities include the ability to store screening hits, identify leads and other compounds, integrate access to tools for structure data mining and compound profiling, hierarchical clustering, and SAR table reporting.
To accommodate users who build gene-centric project models, the software allows advanced analytical capabilities for finding similar genes and patterns, thus enabling users to locate and categorize important genes faster.
In addition, the software allows advanced powerful algorithms: hierarchical and K-means clustering, key-based clustering, decision-tree analysis, and summary-table.
